Market News (Page 2) - TendieTensor

Market News Page 2 of 234 • 5,840 articles

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran

12/26/2025 10:55 AM • A securities class action has been filed against Freeport-McMoran for allegedly making false statements about safety at its Grasberg Block Cave mine in Indonesia. Following a September 2025 incident where a wet material flow trapped seven workers, resulting in two deaths and five missing, the company's stock fell significantly. The lawsuit alleges the company failed to disclose inadequate safety precautions and heightened regulatory and reputational risks. The deadline to seek lead plaintiff status is January 12, 2026.

FCX - The company faces a federal securities class action alleging it made false/misleading statements about safety at its Indonesian mine. A tragic incident resulted in worker deaths and significant stock price declines (5.9%, 17%, and 6.2% on consecutive days in September 2025). The lawsuit claims inadequate safety precautions and undisclosed regulatory and reputational risks, indicating serious operational and legal challenges.

#securities litigation #class action lawsuit #mining safety #Grasberg mine #Indonesia #worker deaths #stock price decline #regulatory risk #false statements #lead plaintiff

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

12/26/2025 10:55 AM • A federal securities class action has been filed against Telix Pharmaceuticals for allegedly making false and misleading statements about its prostate cancer therapeutic candidates and supply chain quality. The company received an SEC subpoena in July 2025 and an FDA Complete Response Letter in August 2025 citing manufacturing deficiencies, resulting in significant stock price declines of 13% and 21% respectively. Investors who purchased securities between February 21 and August 28, 2025 are encouraged to contact the law firm by the January 9, 2026 deadline to seek lead plaintiff status.

XOM - Mentioned as industry peer with strong dividend history, but not primary focus of recommendation
TLX - The company faces federal securities litigation alleging material misstatements about drug development progress and supply chain quality. SEC subpoena and FDA rejection of a key product application citing manufacturing deficiencies resulted in significant stock price declines (13-21%), indicating serious regulatory and operational challenges.

#securities fraud #class action lawsuit #prostate cancer therapeutics #FDA Complete Response Letter #manufacturing deficiencies #SEC investigation #investor losses

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride

12/26/2025 10:53 AM • A securities class action has been filed against Stride, Inc. (NYSE: LRN) alleging the company made false statements about its products and services while inflating enrollment numbers, cutting costs improperly, and ignoring compliance requirements. The allegations emerged after a September 2025 complaint from Gallup-McKinley County Schools and October 2025 earnings revelations of enrollment challenges, causing significant stock price declines of 11.7% and up to 51% respectively.

LRN - The company faces serious allegations of fraud, including inflating enrollment numbers with 'ghost students,' improper cost-cutting, and compliance violations. Stock price declined 11.7% on initial fraud allegations and up to 51% following earnings revelations of enrollment challenges and execution issues, resulting in a federal securities class action lawsuit.

#securities litigation #class action #fraud allegations #enrollment inflation #compliance violations #stock price decline #lead plaintiff deadline

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly

12/26/2025 10:53 AM • A securities law firm is investigating Firefly Aerospace for allegedly making false statements about its Spacecraft Solutions demand and Alpha rocket program viability. Following disappointing Q2 earnings (revenue down 26.2% YoY, Spacecraft Solutions down 49%) and a failed Alpha Flight 7 rocket test in late September 2025, the company's stock plummeted 36% in two weeks. Investors have until January 12, 2026 to seek lead plaintiff status in the class action lawsuit.

RIVN - Mentioned as a conference participant with no specific context about their performance or activities
FLY - Company faces federal securities fraud allegations for misrepresenting demand and operational readiness. Q2 earnings significantly missed expectations with 26.2% revenue decline and 49% drop in key business segment. Two rocket launch failures (April and September 2025) raised viability concerns. Stock price fell 36% over two weeks following disclosures.

#securities fraud #class action lawsuit #IPO #rocket launch failure #earnings miss #stock decline #aerospace #lead plaintiff

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CarMax

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CarMax

12/26/2025 10:50 AM • Faruqi & Faruqi, LLP is investigating potential securities law violations by CarMax, alleging the company made false statements about growth prospects that were temporarily boosted by tariff-related speculation. Following the September 25, 2025 disclosure of an 11.2% decrease in CarMax Auto Finance income and increased loan loss provisions, CarMax stock fell approximately 20% to $45.60 per share. The firm is seeking a lead plaintiff for the class action lawsuit with a January 2, 2026 deadline.

KMX - CarMax faces a federal securities class action lawsuit alleging executives made false and misleading statements about growth prospects. The company disclosed significantly increased loan loss provisions and a 20% stock price decline following earnings results, indicating deteriorating financial performance and investor confidence.

#securities litigation #class action lawsuit #false statements #loan loss provisions #stock price decline #tariff speculation #lead plaintiff

ECD Auto Design Expands 2026 Lineup With Heritage Coupes, Classic SUVs

Benzinga • Akanksha Bakshi

ECD Auto Design Expands 2026 Lineup With Heritage Coupes, Classic SUVs

12/26/2025 10:48 AM • ECD Automotive Design announced a major expansion of its 2026 product lineup, introducing heritage-inspired coupes, classic SUVs, and modern lifestyle 4x4s. The company is restructuring its classic SUV business into Heritage and Custom divisions with dedicated production lines, adding modern safety features like ABS and remote locking systems. ECD is also expanding modern programs through Chelsea Truck Company USA across multiple platforms including Land Rover Defender, Range Rover, and Toyota Land Cruiser. The company implemented a 1-for-5 reverse stock split effective December 26, 2025.

ECDA - The company announced a comprehensive expansion of its 2026 product lineup with new model families, deeper engineering refinement, and broader integration of modern features. CEO highlighted 2026 as a 'breakthrough year' with the most comprehensive portfolio to date. However, the recent reverse stock split may indicate prior stock price weakness, which is a cautionary note.

#product expansion #heritage vehicles #classic SUVs #modern safety features #reverse stock split #bespoke automotive manufacturing #Chelsea Truck Company USA

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience

12/26/2025 10:47 AM • Law firm Faruqi & Faruqi is investigating potential securities fraud claims against Skye Bioscience following the company's announcement that its drug nimacimab failed to meet primary endpoints in a Phase 2a clinical trial. The disclosure of lower-than-expected drug exposure and failure to achieve weight loss compared to placebo resulted in a 60% stock price decline on October 6, 2025. Investors who purchased securities between November 4, 2024 and October 3, 2025 are encouraged to contact the firm, with a January 16, 2026 deadline to seek lead plaintiff status.

MRSN - Being acquired at $25 per share with potential additional milestone payments, representing a strategic exit for the company
SKYE - The company faces securities litigation alleging false and misleading statements about its drug candidate nimacimab's effectiveness. The clinical trial failure resulted in a 60% stock price drop, and executives are accused of overstating the drug's clinical, regulatory, and commercial prospects.

#securities fraud #class action lawsuit #clinical trial failure #nimacimab #stock price decline #lead plaintiff #drug development

Colgate Looks Mispriced as Value, Yield, and Buybacks Start to Line Up

Investing.com • Thomas Hughes

Colgate Looks Mispriced as Value, Yield, and Buybacks Start to Line Up

12/26/2025 10:41 AM • Colgate-Palmolive (CL) is positioned as an attractive buy-and-hold opportunity for consumer staples investors. The stock trades at historically low valuations with a 2.65% dividend yield, strong capital return programs including a $5 billion buyback authorization, and technical indicators suggesting a potential reversal in early 2026. Analysts forecast potential 100% upside over 5-10 years as the company is expected to accelerate growth with a low bar set for Q4 results.

CL - The article presents multiple bullish catalysts including historically low valuations relative to historical norms, a reliable high-yielding dividend (2.65%), active share buyback program ($5 billion authorization), institutional accumulation throughout 2025, technical chart setup suggesting a bottom formation with bullish momentum indicators, and analyst expectations for accelerating growth with low Q4 expectations setting up for potential outperformance. Forecasts suggest 100% stock price upside over 5-10 years.

#Colgate-Palmolive #dividend aristocrat #value investing #share buybacks #technical reversal #consumer staples #capital returns

Forget Rigetti Computing: This Quantum Stock Offers a Far Better Risk‑Reward Right Now

The Motley Fool • Geoffrey Seiler

Forget Rigetti Computing: This Quantum Stock Offers a Far Better Risk‑Reward Right Now

12/26/2025 10:35 AM • While Rigetti Computing achieved quantum computing milestones in 2025, including a 100+-qubit chiplet system, the company faces challenges with error-prone technology (99.5% fidelity) and cash burn. IBM presents a better risk-reward alternative as a quantum-first company with two complementary chip strategies (Nighthawk for quantum advantage and Loon for fault-tolerance), backed by a solid core business generating substantial operating cash flow.

RGTI - Despite achieving hardware milestones and commercial contracts, Rigetti's 99.5% fidelity is considered extremely error-prone (industry standard requires 99.9%), the company has minimal revenue, is burning through cash, and was not selected for DARPA's Quantum Benchmarking Initiative second phase, making it a highly speculative investment.

#quantum computing #Rigetti Computing #IBM #quantum chips #fidelity #error-prone technology #cash burn #Nighthawk chip #Loon chip #Qiskit platform

INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/26/2025 09:50 AM • The Schall Law Firm is seeking investors who purchased Inspire Medical Systems (INSP) securities between August 6, 2024 and August 4, 2025 to join a class action lawsuit alleging securities fraud. The firm claims the company made false statements about its Inspire V device launch, claiming it was fully prepared with high demand when in reality the launch was disastrous with weak market adoption.

EPD - Stable midstream infrastructure, consistent 27-year distribution history, 7% yield, low-risk 'toll taker' business model
INSP - The company is accused of making false and misleading statements about its Inspire V device launch, claiming full preparedness and high demand when the launch was actually disastrous with weak clinician adoption. This represents material misrepresentation to investors resulting in documented losses.

#securities fraud #class action lawsuit #Inspire V launch #false statements #investor losses #medical device

KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/26/2025 09:40 AM • The Schall Law Firm is seeking investors who purchased CarMax securities between June 20, 2025 and September 24, 2025 to join a class action lawsuit alleging securities fraud. CarMax allegedly made false and misleading statements by overstating growth prospects, with actual growth driven by temporary customer speculation about vehicle tariffs rather than genuine business performance.

TOT - Proactively transitioning to renewable energy, 17% clean energy growth in 2024, 6.1% dividend yield, committed to energy transition unlike peers
KMX - The company is accused of making false and misleading statements about growth prospects, with actual growth artificially inflated by temporary tariff speculation rather than genuine business fundamentals. This resulted in investor losses when the truth was revealed.

#securities fraud #class action lawsuit #CarMax #false statements #investor losses #tariff speculation

DAILY JOURNAL CORPORATION ADDRESSES BUXTON HELMSLEY’S BRAZEN THREATS AND EXPOSES THE FIRM’S DISINGENUOUS, SELF-SERVING AGENDA

GlobeNewswire Inc. • Daily Journal Corporation

DAILY JOURNAL CORPORATION ADDRESSES BUXTON HELMSLEY’S BRAZEN THREATS AND EXPOSES THE FIRM’S DISINGENUOUS, SELF-SERVING AGENDA

12/26/2025 09:00 AM • Daily Journal Corporation has rejected demands from activist investor Alexander Erwin Parker of Buxton Helmsley USA, Inc., who threatened a proxy contest and disciplinary referrals against board members and executives unless the company agreed to capitalize software development costs and provide Parker with board seats and a lucrative consulting contract. The company has referred Parker and Buxton Helmsley to federal and state authorities for potential criminal prosecution and stands firmly behind its accounting practices and financial statements.

DJCO - The company faces aggressive activist pressure, threats of proxy contests, and reputational attacks from a shareholder activist. While the company defends its accounting practices and governance, the situation creates uncertainty and potential for costly proxy battles and regulatory scrutiny.

#activist investor #proxy contest #software accounting #ASC 985-20 #board threats #shareholder dispute #financial reporting #corporate governance

MILFAM LLC ANNOUNCES INTENTION TO PROCEED WITH ANNUAL GENERAL MEETING OF SCULLY ROYALTY LTD.

GlobeNewswire Inc. • Milfam Llc

MILFAM LLC ANNOUNCES INTENTION TO PROCEED WITH ANNUAL GENERAL MEETING OF SCULLY ROYALTY LTD.

12/26/2025 09:00 AM • MILFAM LLC, a major shareholder of Scully Royalty Ltd., announced it will proceed with the scheduled Annual General Meeting on December 27, 2025, despite the Board's attempt to postpone it. MILFAM controls over 58% of outstanding shares and plans to elect its slate of director nominees and vote against current board members, citing the Board's lack of authority to postpone and its breach of fiduciary duties.

SRL - The company faces significant governance conflict with its largest shareholder challenging the Board's authority and fiduciary duties. The Board's attempted postponement of the Annual Meeting and the resulting shareholder confrontation indicate internal corporate governance issues and potential instability in leadership.

#Annual General Meeting #shareholder dispute #board postponement #proxy fight #fiduciary duty #director election #majority shareholder

BTDR Investors Have Opportunity to Lead Bitdeer Technologies Group Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

BTDR Investors Have Opportunity to Lead Bitdeer Technologies Group Securities Fraud Lawsuit with the Schall Law Firm

12/26/2025 09:00 AM • The Schall Law Firm is seeking investors who purchased Bitdeer Technologies Group securities between June 6, 2024 and November 10, 2025 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about its SEALMINER A4 project, concealing that the A4 rigs would not be capable of utilizing the SEAL04 chip for energy efficiency because the chip was not ready for production.

RJFpB - Mentioned as a conference host with no specific positive or negative context
BTDR - The company is accused of making false and misleading statements to investors regarding its SEALMINER A4 project and concealing that the SEAL04 chip was not ready for production, resulting in investor losses and triggering a securities fraud class action lawsuit.

#securities fraud #class action lawsuit #Bitdeer Technologies Group #SEALMINER A4 #SEAL04 chip #misleading statements #investor losses

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/26/2025 09:00 AM • The Schall Law Firm is seeking investors to join a class action lawsuit against DexCom, Inc. for securities fraud. The complaint alleges that DexCom made unauthorized changes to its G6 and G7 glucose monitoring systems without FDA approval, resulting in reduced reliability and health risks to users. The company allegedly downplayed the severity of these risks in public statements during the class period from July 26, 2024 to September 17, 2025.

RJF - Mentioned as a conference host with no specific positive or negative context
DXCM - The company is accused of making false and misleading statements, making unauthorized product changes without FDA approval, reducing product reliability, and downplaying health risks to consumers. These allegations of fraud and regulatory violations represent significant legal and reputational risks.

#securities fraud #class action lawsuit #DexCom #FDA authorization #product reliability #shareholder litigation #G6 and G7 systems

GraniteShares Announces Weekly Distributions for its YieldBOOST FoFs ETFs: YBST and YBTY

GlobeNewswire Inc. • Graniteshares Inc.

GraniteShares Announces Weekly Distributions for its YieldBOOST FoFs ETFs: YBST and YBTY

12/26/2025 08:58 AM • GraniteShares announced weekly distributions for its YieldBOOST FoFs ETFs YBST and YBTY on December 26, 2025. YBTY distributed $0.4616 per share with an 89.15% distribution rate, while YBST distributed $0.3904 per share with an 83.19% distribution rate. Both ETFs employ put-writing strategies to generate income, which caps upside potential while exposing investors to downside risk.

YBTY - The ETF shows strong distribution metrics with an 89.15% distribution rate, but this is offset by significant risk disclosures regarding the put-writing strategy's limitations and potential for losses. The neutral sentiment reflects the balance between attractive income generation and substantial downside risks.

#YieldBOOST ETFs #weekly distributions #put-writing strategy #income generation #distribution rate #NAV #option premium

Nexxen Announces Updates to 2025 Annual General Meeting Proposals

GlobeNewswire Inc. • Nexxen International Ltd.

Nexxen Announces Updates to 2025 Annual General Meeting Proposals

12/26/2025 08:45 AM • Nexxen International Ltd. (NASDAQ: NEXN) announced the publication of a Supplemental Proxy Statement for its December 30, 2025 Annual General Meeting of Shareholders. The updated proposals reflect changes to Board composition and compensation arrangements based on shareholder input, intended to better align with shareholder interests. The Board recommends voting in favor of all AGM proposals.

BNCWW - The announcement is procedural in nature, disclosing updates to AGM proposals based on shareholder feedback. While the company's responsiveness to shareholder input is positive, the article contains no material business developments, financial results, or strategic announcements that would indicate positive or negative momentum. The forward-looking statements section highlights significant risks including global economic conditions, conflicts, and regulatory challenges, which temper any positive sentiment.

#Annual General Meeting #Proxy Statement #Board of Directors #Shareholder voting #Compensation arrangements #Corporate governance

City of Cedar Rapids, IA Selects 374Water to Perform Project for PFAS Destruction in Biosolids

GlobeNewswire Inc. • Na

City of Cedar Rapids, IA Selects 374Water to Perform Project for PFAS Destruction in Biosolids

12/26/2025 08:31 AM • 374Water Inc. announced a partnership with Cedar Rapids Water Pollution Control Facility and Brown and Caldwell to evaluate its AirSCWO technology for destroying PFAS-contaminated biosolids. The project will commence in Q1 2026, with results expected by end of Q1 or early Q2 2026. The initiative aims to help Cedar Rapids meet regulatory compliance and establish new standards for PFAS waste management.

SCWO - The company secured a partnership with a major municipal facility to validate its AirSCWO technology for PFAS destruction, demonstrating market traction and potential for scalability. The project represents a meaningful commercial opportunity and positions 374Water as a solution provider for an increasingly important environmental challenge.

#PFAS destruction #biosolids treatment #AirSCWO technology #wastewater management #Cedar Rapids #waste treatment #regulatory compliance

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

GlobeNewswire Inc. • Na

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

12/26/2025 08:00 AM • LifeMD, Inc. announced a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on January 15, 2026. The announcement reflects the company's financial stability as a leading virtual primary care provider.

MSpK - Mentioned as a conference host with no specific positive or negative context
LFMD - The company is declaring a dividend on preferred stock, which indicates financial stability and profitability. Additionally, the article references strong Q3 2025 results with 13% revenue growth and 20% adjusted EBITDA growth, along with recognition from Deloitte and TIME, all signaling positive business momentum.

#preferred dividend #virtual primary care #telemedicine #pharmacy services #financial performance

VCI Global Unveils 2026 “Sovereign RWA Ecosystem” Roadmap: Proprietary Exchange to Anchor Multi-Sector Asset Tokenization

GlobeNewswire Inc. • Vci Global Limited

VCI Global Unveils 2026 “Sovereign RWA Ecosystem” Roadmap: Proprietary Exchange to Anchor Multi-Sector Asset Tokenization

12/26/2025 07:59 AM • VCI Global announced its 2026 strategic roadmap centered on launching a proprietary Real-World Asset (RWA) Exchange designed to support institutional tokenization and secondary trading across precious metals, ESG projects, real estate, and infrastructure. The exchange will leverage Oobit digital payment infrastructure with Tether integration for liquidity, and VCI Global is serving as a consultant for a US$200 million Bridge Gold mandate backed by physical gold.

MSpL - Mentioned as a conference host with no specific positive or negative context
VCIG - Company is announcing significant strategic expansion with a proprietary RWA Exchange launch, securing major institutional mandates (US$200M Bridge Gold), establishing partnerships with established players (Tether/Oobit), and positioning itself as a key player in the emerging tokenized assets market. The roadmap demonstrates growth ambitions and institutional-grade infrastructure development.

#RWA Exchange #asset tokenization #precious metals #real estate #infrastructure #digital assets #Tether #stablecoin #blockchain #capital markets

How Netflix, Paramount Sparked A $108 Billion Media War For Warner Bros. Discovery

Benzinga • Eva Mathew

How Netflix, Paramount Sparked A $108 Billion Media War For Warner Bros. Discovery

12/26/2025 07:50 AM • Warner Bros. Discovery faces competing acquisition bids in a high-stakes media battle. Netflix's $82.7 billion offer was initially favored by the board, but Paramount launched a $108 billion hostile takeover bid backed by Larry Ellison's $40.4 billion personal guarantee. The bidding war also involves Comcast, with Paramount urging shareholders to tender shares by January 21, 2026.

MSpO - Mentioned as a conference host with no specific positive or negative context
WBD - Company is subject to hostile takeover bid and shareholder pressure; facing uncertainty and potential loss of independence

#hostile takeover #media acquisition #streaming wars #Warner Bros. Discovery #bidding war #M&A

Zeekr Drives Off Wall Street, Heralding Chilly Year Ahead For U.S. Chinese Listings

Benzinga • Bamboo Works

Zeekr Drives Off Wall Street, Heralding Chilly Year Ahead For U.S. Chinese Listings

12/26/2025 07:47 AM • Zeekr, a Chinese EV maker, delisted from the NYSE after parent company Geely completed its privatization plan less than two years after the company's IPO. The delisting reflects both company-specific challenges and a broader hostile environment for Chinese companies on Wall Street. Chinese IPO fundraising on U.S. exchanges totaled only $1.12 billion in 2025 across 63 companies, down significantly from $1.91 billion in 2024, with Zeekr's departure potentially signaling more Chinese companies may seek listings in Hong Kong and Shanghai instead.

MSpP - Mentioned as a conference host with no specific positive or negative context
BLBLF - Online video giant mentioned as an early investor who protested Zeekr's privatization offer. No direct operational impact mentioned.

#Chinese IPOs #Wall Street delisting #EV market #privatization #regulatory hostility #Hong Kong listings

Jeffs’ Brands to Sell Approximately 7% of Fort Technology’s Outstanding Shares Reflecting up to CAD $20 million Valuation for Fort Technology

GlobeNewswire Inc. • Na

Jeffs’ Brands to Sell Approximately 7% of Fort Technology’s Outstanding Shares Reflecting up to CAD $20 million Valuation for Fort Technology

12/26/2025 07:42 AM • Jeffs' Brands announced the sale of 1,428,571 common shares of Fort Technology Inc. (approximately 7.4% of Fort's outstanding shares) to institutional investors for CAD $928,571, valuing Fort at CAD $12.5 million (up to CAD $20 million fully diluted). The transaction is part of Jeffs' Brands' strategic pivot from retail e-commerce to homeland security and advanced technologies. Following the sale, Jeffs' Brands will maintain majority control of Fort.

MSpQ - Mentioned as a conference host with no specific positive or negative context
JFBR - The company is executing a strategic transition from e-commerce to homeland security with a partial divestment to raise liquidity. While the pivot shows strategic intent, the sale of assets and reliance on forward-looking statements about new markets present both opportunities and execution risks.

#share sale #divestment #strategic pivot #homeland security #liquidity #majority stake #institutional investors

DeFi Crypto Mutuum Finance (MUTM) Details V1 Launch Roadmap as Phase 7 is Approaching

GlobeNewswire Inc. • Not Specified

DeFi Crypto Mutuum Finance (MUTM) Details V1 Launch Roadmap as Phase 7 is Approaching

12/26/2025 05:00 AM • Mutuum Finance (MUTM), a decentralized lending and borrowing protocol, has raised $19.45M and sold 825M tokens across multiple presale phases. The project plans to launch its V1 on Sepolia testnet in Q4 2025, featuring liquidity pools, mtTokens, and support for ETH and USDT. The token has appreciated 250% from its initial $0.01 price to $0.035, with security audits underway by Halborn Security and a $50k bug bounty program in place.

MSpF - Mentioned as a conference host with no specific positive or negative context
GLNK - Chainlink is mentioned as the anticipated oracle infrastructure provider for Mutuum Finance's price data feeds. This represents a potential use case but does not constitute material news for Chainlink itself.

#DeFi #lending protocol #decentralized finance #token presale #smart contracts #collateral management #liquidation mechanisms #oracle integration #testnet launch #security audit

Prediction: 1 Hypergrowth Stock That Will Run Circles Around Nvidia Through 2030

The Motley Fool • Harsh Chauhan

Prediction: 1 Hypergrowth Stock That Will Run Circles Around Nvidia Through 2030

12/26/2025 04:35 AM • Micron Technology is positioned to outperform Nvidia through 2030 due to surging demand for memory chips driven by AI infrastructure expansion. With a PEG ratio of 0.53 versus Nvidia's 0.69, Micron is trading at an attractive valuation while experiencing phenomenal growth, with revenue projected to jump 130% and earnings to increase 440% in Q2 fiscal 2026. Analysts project the HBM memory market could reach $100 billion by 2028, supporting sustained growth through the decade.

MSpI - Mentioned as a conference host with no specific positive or negative context
MU - Strong revenue and earnings growth (57% and 167% YoY respectively), exceptional forward guidance (130% revenue growth, 440% earnings growth projected), attractive PEG ratio of 0.53 indicating undervaluation, and positioned to benefit from sustained AI infrastructure spending through 2030.

#AI chips #memory chips #semiconductor #HBM (high-bandwidth memory) #data center #valuation #growth stock #AI infrastructure